1
|
Ito A, Katagiri Y, Oigawa S, Amano K, Ichizawa K, Tokuda Y, Unagami M, Yoneyama M, Tsuchiya T, Sekiguchi M, Furui M, Nakaoka K, Umemura N, Hayashi Y, Tamaki Y, Nagao K, Nakata M. Effect of blastocyst shrinkage on assisted reproductive outcomes: a retrospective cohort study describing a new morphological evaluation of blastocyst pre-vitrification and post-warming. J Ovarian Res 2023; 16:192. [PMID: 37710287 PMCID: PMC10503151 DOI: 10.1186/s13048-023-01276-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2023] [Accepted: 09/05/2023] [Indexed: 09/16/2023] Open
Abstract
BACKGROUND The failure of frozen-thawed blastocysts to re-expand adequately within a few hours after warming has been reported to have a negative impact on assisted reproductive technology (ART) outcomes. However, the extent to which this failure truly affects ART outcomes has not yet been presented in a manner that is easily understandable to medical practitioners and patients. This study aimed to assess the effects of blastocyst shrinkage on ART outcomes and determine a more effective morphological evaluation approach for use in clinical settings. METHODS This retrospective observational cohort study of frozen-thawed blastocyst transfer cycles was conducted from April 2017 to March 2022. Overall, 1,331 cycles were eligible for inclusion, of which 999 were good-quality blastocysts (GQB) and 332 were non-good-quality blastocysts (non-GQB). All frozen-thawed blastocyst transfer cycles performed during the specified study period were included in the study. Exclusion criteria were established to mitigate potential sources of bias as these cycles could impact implantations. We calculated rates and age-adjusted odds ratios of implantation, clinical pregnancy, ongoing pregnancy, and live birth of the re-expansion group, which showed sufficient expansion, and shrinkage group, which showed insufficient expansion. We also calculated the implantation, clinical pregnancy, ongoing pregnancy, and live birth rates of the re-expansion and shrinkage groups for each morphological scoring system parameter. RESULTS A reduced ART outcome was observed with use of blastocysts with shrinkage after vitrification/warming. The age-adjusted odds ratios for implantation, clinical pregnancy, ongoing pregnancy, and live birth were lower in the shrinkage group than in the re-expansion group. CONCLUSIONS This study examined the adverse effect of blastocyst shrinkage after warming and recovery culturing on reproductive outcomes in a clinically useful manner by retrospectively examining a substantial number of frozen-thawed embryo transfer cycles. The study findings can possibly reduce concerns regarding over- or under-estimation of blastocyst implantation by allowing providers and patients to refer to the data.
Collapse
Affiliation(s)
- Ayumo Ito
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan.
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan.
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan.
| | - Yukiko Katagiri
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Satoko Oigawa
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Kenji Amano
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Koichiro Ichizawa
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Yukiko Tokuda
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Mami Unagami
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Masato Yoneyama
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Takahiro Tsuchiya
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Mami Sekiguchi
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Mayuko Furui
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Kentaro Nakaoka
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Nahomi Umemura
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Yuko Hayashi
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Yuko Tamaki
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Koichi Nagao
- Reproduction Center, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
- Department of Urology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| | - Masahiko Nakata
- Department of Obstetrics and Gynecology, Faculty of Medicine, Toho University, 5-21-16, Omorinishi, Ota-Ku, Tokyo, 143-0015, Japan
- Department of Obstetrics and Gynecology, Toho University Omori Medical Center, 6-11-1, Omorinishi, Ota-Ku, Tokyo, 143-8541, Japan
| |
Collapse
|
3
|
Cimadomo D, Sosa Fernandez L, Soscia D, Fabozzi G, Benini F, Cesana A, Dal Canto MB, Maggiulli R, Muzzì S, Scarica C, Rienzi L, De Santis L. Inter-centre reliability in embryo grading across several IVF clinics is limited: implications for embryo selection. Reprod Biomed Online 2021; 44:39-48. [PMID: 34819249 DOI: 10.1016/j.rbmo.2021.09.022] [Citation(s) in RCA: 16] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/07/2021] [Revised: 09/01/2021] [Accepted: 09/26/2021] [Indexed: 12/26/2022]
Abstract
RESEARCH QUESTION What is the intra- and inter-centre reliability in embryo grading performed according to the Istanbul Consensus across several IVF clinics? DESIGN Forty Day 3 embryos and 40 blastocysts were photographed on three focal planes. Senior and junior embryologists from 65 clinics were invited to grade them according to the Istanbul Consensus (Study Phase I). All participants then attended interactive training where a panel of experts graded the same embryos (Study Phase II). Finally, a second set of pictures was sent to both embryologists and experts for a blinded evaluation (Study Phase III). Intra-centre reliability was reported for Study Phase I as Cohen's kappa between senior and junior embryologists; inter-centre reliability was instead calculated between senior/junior embryologists and experts in Study Phase I versus III to outline improvements after training (i.e. upgrade of Cohen's kappa category according to Landis and Koch). RESULTS Thirty-six embryologists from 18 centres participated (28% participation rate). The intra-centre reliability was (i) substantial (0.63) for blastomere symmetry (range -0.02 to 1.0), (ii) substantial (0.72) for fragmentation (range 0.29-1.0), (iii) substantial (0.66) for blastocyst expansion (range 0.19-1.0), (iv) moderate (0.59) for inner cell mass quality (range 0.07-0.92), (v) moderate (0.56) for trophectoderm quality (range 0.01-0.97). The inter-centre reliability showed an overall improvement from Study Phase I to III, from fair (0.21-0.4) to moderate (0.41-0.6) for all parameters under analysis, except for blastomere fragmentation among senior embryologists, which was already moderate before training. CONCLUSIONS Intra-centre reliability was generally moderate/substantial, while inter-centre reliability was just fair. The interactive training improved it to moderate, hence this workflow was deemed helpful. The establishment of external quality assessment services (e.g. UK NEQAS) and the avant-garde of artificial intelligence might further improve the reliability of this key practice for embryo selection.
Collapse
Affiliation(s)
| | | | - Daria Soscia
- GeneraLife IVF, Clinica Valle Giulia, Rome, Italy
| | | | | | - Amalia Cesana
- Humanitas Clinical and Research Center-IRCCS, Rozzano, Italy
| | | | | | | | - Catello Scarica
- European Hospital, Center for Reproductive Medicine, Rome, Italy
| | - Laura Rienzi
- GeneraLife IVF, Clinica Valle Giulia, Rome, Italy
| | - Lucia De Santis
- Centro Scienze Natalità, Dept Ob/Gyn, IRCCS San Raffaele Scientific Institute, Milan, Italy
| |
Collapse
|